Lumacip Plus Cream 15 gm

About Lumacip Plus Cream:

Lumacip Plus cream is an antifungal cream for topical application. Lumacip Plus cream contains Fluocinolone acetonide  0.01% w/w, Hydroquinone 4% w/w, Tretinoin Ph. Eur 0.05% w/w, in a cream base q.s. Fluocinolone acetonide is a synthetic fluorinated corticosteroid for topical dermatological use and is classified therapeutically as an anti-inflammatory. Hydroquinone is classified therapeutically as a depigmenting agent. It is prepared from the reduction of p-benzoquinone with sodium bisulphite. Tretinoin is all-trans-retinoic acid, which is formed from the oxidation of the aldehyde group of retinene to a carboxyl group. Tretinoin is classified therapeutically as a keratolytic.

Use of Lumacip Plus Cream:

• Melasma is the most common hyperpigmentation disorder affecting millions of people worldwide. Lumacip Plus cream is indicated for the short-term treatment of moderate-to-severe melasma of the face, in the presence of measures for sun avoidance, including the use of sunscreens.
• Lumacip Plus cream, is not indicated for the maintenance treatment of melasma. After achieving control with Lumacip Plus cream, some patients may be managed with other treatments. Melasma usually recurs upon discontinuation of Lumacip Plus cream.

Usage direction of Lumacip Plus 15 gm Cream:

• Lumacip Plus 15 gm cream should be applied topically as per doctor’s advice. Doctor will decide the right amount and the duration of use as per the patient condition.
• Apply a thin film of Lumacip Plus cream to the affected area once daily, at least 30 minutes before bedtime.
• Gently wash the face and neck with a mild cleanser.
• Rinse and pat the skin dry.
• Apply a thin film of the cream to the hyperpigmented areas of melasma, including about half-inch of the normal-appearing skin surrounding each lesion.
• Rub lightly and uniformly into the skin.
• Application of Lumacip Plus cream should be kept away from the eyes, nose or angles of the mouth.

 Precaution & Related Information of Lumacip Plus Cream:

• Do not use Lumacip Plus cream if you are allergic (hypersensitive) to any of the ingredients in the product. If irritation develops, Lumacip Plus cream should be discontinued and appropriate therapy instituted. Therapy should be discontinued when control is achieved.
• The cream is for external use only. In case of use on the face, avoid contact with the eyes. In case of accidental contact with the eyes, rinse thoroughly with running water.
• Lumacip Plus cream contains hydroquinone, which may produce exogenous ochronosis, a gradual blue-black darkening of the skin, the occurrence of which should prompt discontinuation of therapy.
• Allergic contact dermatitis, blistering, crusting and severe burning or swelling of the skin and irritation of the mucous membranes of the eyes, nose and mouth require medical attention.
• During the day, use a sunscreen of SPF 30, and wear protective clothing. Avoid sunlight exposure. Patients may use moisturizers and/or cosmetics during the day.
• Safety and effectiveness of Lumacip Plus cream in paediatric patients have not been established.
• Dose selection for an elderly patient should be cautious.
• Pregnancy and Lactation: There are no adequate and well-controlled studies in pregnant women. Lumacip Plus cream should be used during pregnancy only if the potential benefit justifies the potential risk to the foetus. Caution should be exercised when Lumacip Plus cream is administered to a nursing mother. Care should be taken to avoid contact between the infant being nursed and Lumacip Plus cream.
• Store below 25°C. Protect from light. Do not freeze.